Clinical trials: Chronic Total Occlusion (CTO)
Chronic Total Occlusions
Collagenase Total Occlusion-1 Trial
A prospective, three-center, phase I safety and tolerability dose escalation study, evaluating 28 subjects in 4 discrete dose cohorts of acute intracoronary injected collagenase ranging from 300 - 1200 µg prior to routine…
- Trial name
- NCT01271335
- Testing
- collagenase
- Where
- Canada
- Volunteers
- 28 people
- Sponsor
- Sunnybrook Health Sciences Centre
Coronary Chronic Total Occlusions
The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO)
A Prospective Follow-up Assessment in Bad Segeberg with Patients undergoing Recanalization for Coronary Chronic Total Occlusion Lesion/s
- Trial name
- CTO Registry (NCT06957613)
- Testing
- Revascularization/Conservative management
- Where
- Germany
- Volunteers
- 1,500 people
- Sponsor
- Segeberger Kliniken GmbH
Chronic Total Coronary Occlusion
The Nordic Baltic Chronic Total Occlusion (CTO) Arrhythmia Study
In patients with a chronic total coronary occlusion (CTO ), clinically significant arrhythmia seems to be an important and a poorly investigated problem.
- Trial name
- NCT04542460
- Testing
- PCI
- Where
- Denmark
- Volunteers
- 200 people
- Sponsor
- Leif Thuesen
Chronic Total Occlusions of Coronary Arteries, Stress Echocardiography (SE)
Predicting Functional Recovery After Coronary Chronic Total Occlusion Revascularization
Chronic total occlusion (CTO) is defined as complete coronary occlusion with TIMI flow grade 0 persisting for more than three months, identified in 15-25% of patients undergoing coronary angiography.¹,² CTO is associated with…
- Conditions
- Chronic Total Occlusions of Coronary Arteries, Stress Echocardiography (SE), Inflammation Biomarkers
- Trial name
- StressECHOCTO (NCT07879573)
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Assiut University